Advertisement
Under the terms of the CRADA, Ingenuity Systems and the FDA will expandIngenuity's content and software solutions to facilitate the research andregulatory review of biomarker, pharmacogenomic, and toxicogenomic data. Thecollaboration directly relates to the FDA's need to develop better tools forthe review of genomic data.
Advertisement
"We are making progress towards the goals outlined in the CRADA,"commented Federico Goodsaid, Ph.D., Associate Director for Operations inGenomics. "We are looking forward to this collaboration over the course ofthis year so our team can benefit from these tools and information availablefrom them on relationships between drugs and potential mechanism of action andmechanism of toxicity."
"Our collaboration with the FDA was a natural partnership givenIngenuity's close alliance with the industry initiatives and healthcare goalslaid out by the Critical Path Initiative," stated Ramon Felciano, Ph.D., CTOand Vice President, Research of Ingenuity Systems. "We are confident that wecan leverage Ingenuity's unique capabilities to provide the FDA with a clearerunderstanding of the biological and chemical relationships embedded in theregulatory data."
About Ingenuity Systems(R)
Ingenuity Systems is a leading provider of information solutions for theexploration, interpretation, and analysis of life science information. All ofIngenuity's products and services have one common goal - to help life scienceresearchers generate maximum value from all types of biological and chemicalknowledge. Ingenuity offers a broad and flexible range of solutions that canbe tailored to needs of various clients, including academic and therapeuticarea researchers, computational biologists and informatics departments, andsuppliers in the life sciences industry. All of the products leverageIngenuity's knowledge base, the largest data base of its kind, which housesthe biological and chemical relationships extracted from scientificliterature. The information is uniquely structured so scientists can askcomplex biological questions to gain rapid insight into their experimentaldata or create relevant biological models to move forward in their research.Today, Ingenuity's solutions are used by thousands of researchers at hundredsof leading pharmaceutical, biotechnology, and academic research institutionsworldwide. Ingenuity was founded in 1998 and is headquartered in Redwood City,California with offices in Germany, Switzerland, France, the United Kingdom,Australia, and Japan. http://www.ingenuity.com.
SOURCE Ingenuity Systems
